search
Back to results

Genetic Susceptibility to Listeriosis (Listeria-GEN)

Primary Purpose

Listeriosis

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Human biological samples
Sponsored by
Institut Pasteur
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Listeriosis

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria for patients with Listeriosis :

  • Microbiologically documented Listeriosis (either a severe form of listeriosis, or an atypical form of listeriosis, or less than 40 years old and without any co-morbidity identified)
  • Affiliated or beneficiary of a social security system
  • Informed and written consent

Inclusion Criteria for volunteers related to patients with Listeriosis (after identifying a genetic susceptibility in the patient with Listeriosis) :

  • defined as father, mother, brother (s), sister (s), child (ren), grandparent (s), uncle (s), aunt (s), cousin (s), nephew (s), niece (s).
  • Affiliated or beneficiary of a social security system
  • Informed and written consent

Exclusion Criteria for volunteers related to patients with Listeriosis:

  • Inability to consent

Sites / Locations

  • Centre Médical de l'Institut PasteurRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Patients with Listeriosis

Volunteers related with patients with Listeriosis

Arm Description

Patients with Listeriosis. Human biological samples : Blood sample Skin biopsy Saliva

Volunteers related with patients with Listeriosis. Human biological samples : Blood sample Skin biopsy Saliva

Outcomes

Primary Outcome Measures

Identification of a susceptibility factor associated with Listeriosis infection
In patients with Listeriosis, the hypothesis that the identified genetic variation is the mutation responsible for the infection will be verified : by verifying that it is not a listed polymorphism by sequencing genomic DNA controls by verifiyng that family genetic segregation is compatible with clinical segregation by verifying the function of the mutated protein in the patient's cell lines and / or fresh cells by performing complementation experiments by transfecting the wild-type allele into the patient's cells

Secondary Outcome Measures

Identification of a susceptibility factor associated with the most severe or atypical forms
In patients with Listeriosis, the susceptibility factor associated with the most severe or atypical forms will be characterized : By testing the response and production of cytokines involved in infection control. By identifying chromosomal regions associated with the disease by a homozygosity mapping genetic study on multiplex and / or inbred families. By sequencing the identified candidate genes.

Full Information

First Posted
November 24, 2017
Last Updated
September 30, 2022
Sponsor
Institut Pasteur
Collaborators
Icahn School of Medicine at Mount Sinai
search

1. Study Identification

Unique Protocol Identification Number
NCT03357536
Brief Title
Genetic Susceptibility to Listeriosis
Acronym
Listeria-GEN
Official Title
Genetic Susceptibility to Listeriosis - Listeria-GEN
Study Type
Interventional

2. Study Status

Record Verification Date
September 2022
Overall Recruitment Status
Recruiting
Study Start Date
November 28, 2017 (Actual)
Primary Completion Date
November 30, 2027 (Anticipated)
Study Completion Date
November 30, 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Institut Pasteur
Collaborators
Icahn School of Medicine at Mount Sinai

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Listeriosis is a rare, severe foodborne infection, responsible for severe invasive infections. It occurs in the great majority of cases in elderly patients and / or patients with comorbidities, with a deficit of innate or cellular immunity. Pregnancy is also a risk factor. The Multicentric Observational NAtional Analysis of Listeriosis and Listeria (MONALISA) is an ongoing national case-control prospective study on listeriosis implemented since 2009 to study risk and prognosis factors for listeriosis. In this cohort, which enrolled 902 patients on 1 August 2014, 7% of patients with neurolisteriosis are under 40 years of age and have no identified risk factor. Genetic susceptibility is suspected in these patients. Genetic susceptibility could also explain the inconstant development of a neurolisteriosis or fetal infection, as well as the particular severity of some infections (death, foetal loss, neurological sequelae). The aim of the study is to identify genetic susceptibility to Listeriosis.
Detailed Description
Listeriosis is a rare, severe foodborne infection caused by the bacterium Listeria monocytogenes (Lm), responsible for severe invasive infections. It occurs in the great majority of cases in elderly patients and / or patients with comorbidities, with a deficit of innate or cellular immunity. Pregnancy is also a risk factor. The Multicentric Observational NAtional Analysis of Listeriosis and Listeria (MONALISA) is an ongoing national case-control prospective study on listeriosis implemented since 2009 to study risk and prognosis factors for listeriosis. In this cohort, which enrolled 902 patients on 1 August 2014, 7% of patients with neurolisteriosis are under 40 years of age and have no identified risk factor. Genetic susceptibility is suspected in these patients. Genetic susceptibility could also explain the inconstant development of a neurolisteriosis or fetal infection, as well as the particular severity of some infections (death, foetal loss, neurological sequelae). The analysis of the genetically transmitted vulnerability of Lm has not yet been studied, because of the lack of accessibility to prospective cohorts (and their DNA) for this rare and severe infection. The aim of the study is to identify genetic susceptibility to Listeriosis that will optimize the patient care in terms of treatment and prevention.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Listeriosis

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Patients with Listeriosis
Arm Type
Experimental
Arm Description
Patients with Listeriosis. Human biological samples : Blood sample Skin biopsy Saliva
Arm Title
Volunteers related with patients with Listeriosis
Arm Type
Experimental
Arm Description
Volunteers related with patients with Listeriosis. Human biological samples : Blood sample Skin biopsy Saliva
Intervention Type
Procedure
Intervention Name(s)
Human biological samples
Intervention Description
Blood sample Skin biopsy Saliva
Primary Outcome Measure Information:
Title
Identification of a susceptibility factor associated with Listeriosis infection
Description
In patients with Listeriosis, the hypothesis that the identified genetic variation is the mutation responsible for the infection will be verified : by verifying that it is not a listed polymorphism by sequencing genomic DNA controls by verifiyng that family genetic segregation is compatible with clinical segregation by verifying the function of the mutated protein in the patient's cell lines and / or fresh cells by performing complementation experiments by transfecting the wild-type allele into the patient's cells
Time Frame
10 years
Secondary Outcome Measure Information:
Title
Identification of a susceptibility factor associated with the most severe or atypical forms
Description
In patients with Listeriosis, the susceptibility factor associated with the most severe or atypical forms will be characterized : By testing the response and production of cytokines involved in infection control. By identifying chromosomal regions associated with the disease by a homozygosity mapping genetic study on multiplex and / or inbred families. By sequencing the identified candidate genes.
Time Frame
10 years

10. Eligibility

Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria for patients with Listeriosis : Microbiologically documented Listeriosis (either a severe form of listeriosis, or an atypical form of listeriosis, or less than 40 years old and without any co-morbidity identified) Affiliated or beneficiary of a social security system Informed and written consent Inclusion Criteria for volunteers related to patients with Listeriosis (after identifying a genetic susceptibility in the patient with Listeriosis) : defined as father, mother, brother (s), sister (s), child (ren), grandparent (s), uncle (s), aunt (s), cousin (s), nephew (s), niece (s). Affiliated or beneficiary of a social security system Informed and written consent Exclusion Criteria for volunteers related to patients with Listeriosis: Inability to consent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Marc Lecuit
Phone
+33 1 40 61 34 20
Email
marc.lecuit@pasteur.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Caroline Charlier-Woerther
Phone
+33 1 40 31 30 10
Email
caroline.charlier@pasteur.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marc Lecuit
Organizational Affiliation
Institut Pasteur
Official's Role
Study Director
Facility Information:
Facility Name
Centre Médical de l'Institut Pasteur
City
Paris
ZIP/Postal Code
75015
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Caroline Charlier-Woerther, MD
Phone
+33 1 40 61 30 10
Email
caroline.charlier@pasteur.fr

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Genetic Susceptibility to Listeriosis

We'll reach out to this number within 24 hrs